🔗 Share this article

Given that the United States proceeds with historic revisions to its vaccination recommendations, an unexpected name has emerged unexpectedly: Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who first made her name by questioning coronavirus shots in the pandemic and has zeroed in on alleged fatalities following Covid vaccination in her recent position at the US Food and Drug Administration (FDA).

Planned Changes to Childhood Vaccine Program

Public health authorities were set to announce sweeping revisions to the childhood vaccine schedule recently, bringing the US with the Danish immunization schedule, sources say – a major change that would place the US at odds with much of the international standard with no evidence for improved outcomes. The planned update has been delayed until the new year.

Rather than the director of the vaccine center, Høeg is listed to speak at the gathering. She was recently named temporary leader of the FDA’s Center for Drug Evaluation and Research (CDER), the fifth individual to lead the office this year.

Consolidating Power at the FDA

Høeg's temporary position may indicate a closer partnership between the pharmaceutical and biologics centers as Dr. Høeg and Dr. Prasad solidify control at the FDA – and it signals a increased emphasis upon rolling back previously authorized immunizations at the FDA.

Dr. Høeg has often pushed for halting specific childhood shot schedules in the US to become more in line with the Danish model, a society with universal health coverage and a population approximately the size of Wisconsin’s.

In her initial public appearances, she has kept her attention on immunizations – usually the domain of Prasad, head of the FDA’s vaccine center – as opposed to drug regulation.

Questions Over Expertise

The appointee has no apparent experience in pharmaceutical research, approval processes or management, which has been typical for past heads of the biologics center. She has worked at the FDA as a key advisor to the commissioner and the vaccine center since spring.

“She doesn’t seem to have the necessary background” for leading the CDER, stated a neurologist and psychiatrist. “She has not conducted a scientific study. She is not versed in running a large organization. She is not an expert in drug approvals.”

Former commissioners of CBER would “understand laws and regulations and the underlying principles of medication creation”, noted Janet Woodcock. “Clearly, she doesn’t have the kind of background that previous people who led the center have had.”

The drug center has an vast workload at the agency, Woodcock pointed out.

“Everybody just pays attention on the new drug program, but the generic program approves numerous generic medications. There’s a biologic copycat branch, over-the-counter program and more, and every single one need to be managed,” Woodcock said. “The area you don’t keep your eye on, that’s the thing that I always told people is going to come back to haunt you.”

Additionally, a significant management component to the position, which manages in excess of 5,000 staff members. “It’s a massive administrative position, if you perform it correctly,” Woodcock concluded.

Response and Controversial Policies

Regarding inquiries about Dr. Høeg's fitness for the role and whether this appointment indicates more teamwork among regulatory chiefs on immunizations, a spokesperson responded that the “questions are based on flawed presumptions”.

“Her experience is consistent with the duties of her position,” the official said, pointing to the time Høeg spent guiding the FDA commissioner on “medication safety and regulatory science, including computational safety modeling and vaccine surveillance”.

In her interim role, Dr. Høeg assumes responsibility for the commissioner’s controversial priority voucher program, a disputed rapid therapy clearance system that apparently worried her former heads. “How are these drugs being picked for this fast-track system? Who is making the choices?” Howard asked. “There’s a lot of confidentiality happening at the regulatory body right now.”

Overall, he said, “the agency appears to be shifting towards less stringent oversight of all drugs, aside from vaccines.”

Documented History on Immunizations

With immunizations, Høeg has a clearer, if problematic, track record, critics observe. She authored a research paper using non-validated volunteer-provided data to determine the incidence of heart inflammation following COVID-19 immunization. She advised the state of Florida surgeon general Dr. Joseph Ladapo, who was said to have modified findings to imply Covid vaccines are more dangerous than they are.

Among her “desired changes” for the current government encompassed changing regulations for recently developed shots and discontinuing “unnecessary” immunizations, she said after the election on a online show. At the agency, Dr. Høeg has allegedly floated the idea of excluding young men from receiving COVID-19 vaccines.

“She is an thorough dogmatist who begins with her conclusions and works backwards to accommodate the science in a extremely misleading, dishonest way,” Dr. Howard argued.

Taking Control and a “Push for Payback”

Høeg became part of other dissenters, {like|